Literature DB >> 10760545

Extraneuronal cholinergic system in lymphocytes.

K Kawashima1, T Fujii.   

Abstract

Acetylcholine (ACh) is well known as a neurotransmitter in both the central and peripheral nervous systems in mammalian species. Both muscarinic and nicotinic ACh receptors have been identified in lymphocytes isolated from thymus, lymph node, spleen, and peripheral blood, and their stimulation by muscarinic and nicotinic agonists elicits a variety of functional and biochemical effects. On the basis of these findings, it has been postulated that the parasympathetic nervous system may play a role in immune-neurohumoral crosstalk. However, ACh present in the blood of several species has been localized to lymphocytes from various origins using radioimmunoassay. Moreover, using Northern blots or reverse transcription-polymerase chain reaction, expression of choline acetyltransferase, an ACh synthesizing enzyme, has been identified in human blood mononuclear leukocytes, human leukemic T-cell lines, and rat lymphocytes. Stimulation of T-lymphocytes with phytohemagglutinin activates the lymphoid cholinergic system, as evidenced by increased synthesis and release of ACh, increased acetylcholinesterase activity, and the increased expression of mRNA encoding choline acetyltransferase and ACh receptors. The observation that muscarinic receptor stimulation by ACh or agonists increases in [Ca(2)+](i) and up-regulates c-fos expression strongly argues that ACh synthesized and released from T-lymphocytes acts as an autocrine and/or paracrine factor regulating immune function. In summary, these data present a compelling picture in which immune function is not only regulated by the cytokine system, but is also under the control of an independent, lymphoid cholinergic system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10760545     DOI: 10.1016/s0163-7258(99)00071-6

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  68 in total

1.  Release of non-neuronal acetylcholine from the isolated human placenta is mediated by organic cation transporters.

Authors:  I Wessler; E Roth; C Deutsch; P Brockerhoff; F Bittinger; C J Kirkpatrick; H Kilbinger
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

2.  Upregulation of mRNA encoding the M5 muscarinic acetylcholine receptor in human T- and B-lymphocytes during immunological responses.

Authors:  Takeshi Fujii; Yoshihiro Watanabe; Tomoyuki Inoue; Koichiro Kawashima
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

Review 3.  The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation.

Authors:  Valentin A Pavlov; Hong Wang; Christopher J Czura; Steven G Friedman; Kevin J Tracey
Journal:  Mol Med       Date:  2003 May-Aug       Impact factor: 6.354

4.  Regional quantification of muscarinic acetylcholine receptors and β-adrenoceptors in human airways.

Authors:  T Ikeda; A S M Anisuzzaman; H Yoshiki; M Sasaki; T Koshiji; J Uwada; A Nishimune; H Itoh; I Muramatsu
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

5.  Analysis of CD8+ T cell-mediated anti-viral responses in mice with targeted deletions of the M1 or M5 muscarinic cholinergic receptors.

Authors:  Vaiva Vezys; David Masopust; Maxime Desmarets; Jürgen Wess; James C Zimring
Journal:  Life Sci       Date:  2007-01-13       Impact factor: 5.037

Review 6.  Cholinergic control of inflammation.

Authors:  M Rosas-Ballina; K J Tracey
Journal:  J Intern Med       Date:  2009-06       Impact factor: 8.989

Review 7.  Muscarinic receptors and ligands in cancer.

Authors:  Nirish Shah; Sandeep Khurana; Kunrong Cheng; Jean-Pierre Raufman
Journal:  Am J Physiol Cell Physiol       Date:  2008-11-26       Impact factor: 4.249

8.  Auto/paracrine control of inflammatory cytokines by acetylcholine in macrophage-like U937 cells through nicotinic receptors.

Authors:  Alexander I Chernyavsky; Juan Arredondo; Maryna Skok; Sergei A Grando
Journal:  Int Immunopharmacol       Date:  2009-12-18       Impact factor: 4.932

Review 9.  Acetylcholinesterase in Hirschsprung's disease.

Authors:  S W Moore; G Johnson
Journal:  Pediatr Surg Int       Date:  2005-03-10       Impact factor: 1.827

10.  Modulation of erythrocyte acetylcholinesterase activity and its association with G protein-band 3 interactions.

Authors:  F A Carvalho; J P Lopes de Almeida; T Freitas-Santos; C Saldanha
Journal:  J Membr Biol       Date:  2009-03-18       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.